Limited-Time Offer Start from $1980. 1000+ Ready-to-Screen Cell Pools.
Location:
Overcome cell input limits in CRISPRi screens. Learn how high-MOI multiplexing accelerates genome-wide target discovery with Ubigene’s library platform.
Explore how genome-wide CRISPR screening revealed PHKG2's role in ESCC cisplatin resistance and tumor microenvironment remodeling, offering new targeted therapy insights.
Discover 5 major reasons why CRISPR editing efficiency varies across cell types and explore actionable solutions, including EZ-HRex™ technology by Ubigene.
Discover how the αKG–TMLHE–carnitine axis drives drug resistance in HR-proficient ovarian cancer by enhancing histone acetylation and DNA repair.
Explore the essential guide to PANC-1 cell culture and gene editing. Discover key morphology traits, subculture protocols, electroporation and lentiviral transduction tips, and expert troubleshooting solutions.